HB Need Injection contains Iron Sucrose (20mg/ml), an intravenous iron preparation indicated for the treatment of iron deficiency anemia in patients who are unable to tolerate or absorb oral iron therapy or require rapid replenishment of iron stores. Iron Sucrose is a complex of polynuclear iron(III)-hydroxide in sucrose, designed to deliver bioavailable iron directly to the reticuloendothelial system for incorporation into hemoglobin synthesis. This formulation is particularly useful in chronic kidney disease patients undergoing hemodialysis, as well as in other clinical conditions associated with iron deficiency anemia, such as postpartum anemia or malabsorption syndromes. Administration should be performed under medical supervision, with dosage individualized based on the patient’s iron deficit, hemoglobin levels, and response to therapy. Common adverse effects may include transient hypotension, nausea, headache, and injection site reactions. Hypersensitivity reactions, although rare, necessitate immediate discontinuation and appropriate management. HB Need Injection offers a reliable and effective option for parenteral iron supplementation, facilitating rapid correction of anemia and improvement of patient quality of life. Proper monitoring of iron parameters and clinical status is essential to avoid iron overload and optimize therapeutic outcomes.